Logo image of BHIL

BENSON HILL INC (BHIL) Stock Fundamental Analysis

NASDAQ:BHIL - Nasdaq - US0824902029 - Common Stock - Currency: USD

0.249  -0.17 (-41.19%)

After market: 0.17 -0.08 (-31.73%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to BHIL. BHIL was compared to 88 industry peers in the Food Products industry. BHIL has a bad profitability rating. Also its financial health evaluation is rather negative. BHIL is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

BHIL had negative earnings in the past year.
BHIL had a negative operating cash flow in the past year.
In the past 5 years BHIL always reported negative net income.
In the past 5 years BHIL always reported negative operating cash flow.
BHIL Yearly Net Income VS EBIT VS OCF VS FCFBHIL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 -50M -100M

1.2 Ratios

BHIL's Return On Assets of -73.99% is on the low side compared to the rest of the industry. BHIL is outperformed by 87.91% of its industry peers.
Looking at the Return On Equity, with a value of -379.14%, BHIL is doing worse than 87.91% of the companies in the same industry.
Industry RankSector Rank
ROA -73.99%
ROE -379.14%
ROIC N/A
ROA(3y)-30.36%
ROA(5y)-33.1%
ROE(3y)-83.39%
ROE(5y)-77.15%
ROIC(3y)N/A
ROIC(5y)N/A
BHIL Yearly ROA, ROE, ROICBHIL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 -20 -40 -60 -80 -100

1.3 Margins

Looking at the Gross Margin, with a value of 5.33%, BHIL is doing worse than 81.32% of the companies in the same industry.
In the last couple of years the Gross Margin of BHIL has declined.
The Profit Margin and Operating Margin are not available for BHIL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 5.33%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.76%
GM growth 5Y-43.1%
BHIL Yearly Profit, Operating, Gross MarginsBHIL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 -100 -200 -300 -400

More info and screens

3

2. Health

2.1 Basic Checks

BHIL does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, BHIL has less shares outstanding
Compared to 1 year ago, BHIL has a worse debt to assets ratio.
BHIL Yearly Shares OutstandingBHIL Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 50M 100M 150M 200M
BHIL Yearly Total Debt VS Total AssetsBHIL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

2.2 Solvency

Based on the Altman-Z score of -6.14, we must say that BHIL is in the distress zone and has some risk of bankruptcy.
BHIL has a worse Altman-Z score (-6.14) than 84.62% of its industry peers.
BHIL has a Debt/Equity ratio of 3.12. This is a high value indicating a heavy dependency on external financing.
BHIL's Debt to Equity ratio of 3.12 is on the low side compared to the rest of the industry. BHIL is outperformed by 85.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.12
Debt/FCF N/A
Altman-Z -6.14
ROIC/WACCN/A
WACC9.33%
BHIL Yearly LT Debt VS Equity VS FCFBHIL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 100M -100M 200M

2.3 Liquidity

BHIL has a Current Ratio of 2.21. This indicates that BHIL is financially healthy and has no problem in meeting its short term obligations.
BHIL has a Current ratio of 2.21. This is in the better half of the industry: BHIL outperforms 67.03% of its industry peers.
BHIL has a Quick Ratio of 1.74. This is a normal value and indicates that BHIL is financially healthy and should not expect problems in meeting its short term obligations.
BHIL has a Quick ratio of 1.74. This is amongst the best in the industry. BHIL outperforms 80.22% of its industry peers.
Industry RankSector Rank
Current Ratio 2.21
Quick Ratio 1.74
BHIL Yearly Current Assets VS Current LiabilitesBHIL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 100M 200M 300M

More info and screens

4

3. Growth

3.1 Past

BHIL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 14.20%, which is quite good.
Looking at the last year, BHIL shows a very negative growth in Revenue. The Revenue has decreased by -49.19% in the last year.
Measured over the past years, BHIL shows a very strong growth in Revenue. The Revenue has been growing by 156.06% on average per year.
EPS 1Y (TTM)14.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-31.43%
Revenue 1Y (TTM)-49.19%
Revenue growth 3Y100.08%
Revenue growth 5Y156.06%
Sales Q2Q%-69.84%

3.2 Future

The Earnings Per Share is expected to grow by 23.04% on average over the next years. This is a very strong growth
The Revenue is expected to decrease by -33.44% on average over the next years. This is quite bad
EPS Next Y40.84%
EPS Next 2Y34.39%
EPS Next 3Y23.04%
EPS Next 5YN/A
Revenue Next Year-71.85%
Revenue Next 2Y-52.14%
Revenue Next 3Y-33.44%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BHIL Yearly Revenue VS EstimatesBHIL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M
BHIL Yearly EPS VS EstimatesBHIL Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 -5 -10 -15 -20 -25

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

BHIL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year BHIL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BHIL Price Earnings VS Forward Price EarningsBHIL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BHIL Per share dataBHIL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 -20 30

4.3 Compensation for Growth

BHIL's earnings are expected to grow with 23.04% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34.39%
EPS Next 3Y23.04%

More info and screens

0

5. Dividend

5.1 Amount

BHIL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BENSON HILL INC

NASDAQ:BHIL (3/26/2025, 8:00:02 PM)

After market: 0.17 -0.08 (-31.73%)

0.249

-0.17 (-41.19%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)03-25 2025-03-25/amc
Earnings (Next)05-07 2025-05-07/bmo
Inst Owners17.2%
Inst Owner Change0%
Ins Owners8.84%
Ins Owner Change0%
Market Cap1.52M
Analysts43.33
Price TargetN/A
Short Float %4.41%
Short Ratio0.4
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-48.82%
Min EPS beat(2)-67.13%
Max EPS beat(2)-30.51%
EPS beat(4)1
Avg EPS beat(4)-40.73%
Min EPS beat(4)-67.24%
Max EPS beat(4)1.96%
EPS beat(8)3
Avg EPS beat(8)-18.22%
EPS beat(12)6
Avg EPS beat(12)-8.43%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)10.88%
Min Revenue beat(2)-14.5%
Max Revenue beat(2)36.26%
Revenue beat(4)2
Avg Revenue beat(4)6.8%
Min Revenue beat(4)-25.47%
Max Revenue beat(4)36.26%
Revenue beat(8)5
Avg Revenue beat(8)7.9%
Revenue beat(12)7
Avg Revenue beat(12)-2.44%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-27.33%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF N/A
P/OCF N/A
P/B 0.06
P/tB 0.07
EV/EBITDA N/A
EPS(TTM)-21.02
EYN/A
EPS(NY)-4.75
Fwd EYN/A
FCF(TTM)-6.91
FCFYN/A
OCF(TTM)-6.55
OCFYN/A
SpS33.65
BVpS4.39
TBVpS3.61
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -73.99%
ROE -379.14%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 5.33%
FCFM N/A
ROA(3y)-30.36%
ROA(5y)-33.1%
ROE(3y)-83.39%
ROE(5y)-77.15%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.76%
GM growth 5Y-43.1%
F-Score3
Asset Turnover1.49
Health
Industry RankSector Rank
Debt/Equity 3.12
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 12.42%
Cap/Sales 1.06%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.21
Quick Ratio 1.74
Altman-Z -6.14
F-Score3
WACC9.33%
ROIC/WACCN/A
Cap/Depr(3y)124.08%
Cap/Depr(5y)136.84%
Cap/Sales(3y)13.82%
Cap/Sales(5y)13.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-31.43%
EPS Next Y40.84%
EPS Next 2Y34.39%
EPS Next 3Y23.04%
EPS Next 5YN/A
Revenue 1Y (TTM)-49.19%
Revenue growth 3Y100.08%
Revenue growth 5Y156.06%
Sales Q2Q%-69.84%
Revenue Next Year-71.85%
Revenue Next 2Y-52.14%
Revenue Next 3Y-33.44%
Revenue Next 5YN/A
EBIT growth 1Y11.69%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year52.41%
EBIT Next 3Y24.07%
EBIT Next 5YN/A
FCF growth 1Y66.33%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y63.14%
OCF growth 3YN/A
OCF growth 5YN/A